These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 16764702
21. High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients. Ostrowski SR, Piironen T, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H. J Acquir Immune Defic Syndr; 2005 May 01; 39(1):23-31. PubMed ID: 15851910 [Abstract] [Full Text] [Related]
22. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production. Andrade RM, Lima PG, Filho RG, Hygino J, Milczanowski SF, Andrade AF, Lauria C, Brindeiro R, Tanuri A, Bento CA. AIDS; 2007 Aug 20; 21(13):1763-70. PubMed ID: 17690575 [Abstract] [Full Text] [Related]
23. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion. Laurichesse JJ, Persoz A, Theodorou I, Rouzioux C, Delfraissy JF, Meyer L. HIV Med; 2007 May 20; 8(4):213-9. PubMed ID: 17461848 [Abstract] [Full Text] [Related]
24. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients]. Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL. Zhonghua Yi Xue Za Zhi; 2007 Nov 13; 87(42):2973-6. PubMed ID: 18261327 [Abstract] [Full Text] [Related]
25. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART. Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F, Mezzaroma I. Clin Infect Dis; 2008 Jun 15; 46(12):1902-10. PubMed ID: 18462177 [Abstract] [Full Text] [Related]
26. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy. Riddler SA, Li X, Chu H, Kingsley LA, Dobs A, Evans R, Palella F, Visscher B, Chmiel JS, Sharrett A. HIV Med; 2007 Jul 15; 8(5):280-7. PubMed ID: 17561873 [Abstract] [Full Text] [Related]
27. Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer. Riisbro R, Christensen IJ, Piironen T, Greenall M, Larsen B, Stephens RW, Han C, Høyer-Hansen G, Smith K, Brünner N, Harris AL. Clin Cancer Res; 2002 May 15; 8(5):1132-41. PubMed ID: 12006529 [Abstract] [Full Text] [Related]
33. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy. Zhang Z, Zhao QX, Fu JL, Yao JX, He Y, Jin L, Wang FS. Chin Med J (Engl); 2006 Dec 05; 119(23):1949-57. PubMed ID: 17199938 [Abstract] [Full Text] [Related]
34. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy. Kolte L, Ryder LP, Albrecht-Beste E, Jensen FK, Nielsen SD. Scand J Immunol; 2009 Dec 05; 70(6):608-13. PubMed ID: 19906203 [Abstract] [Full Text] [Related]
36. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy. Giralt M, Domingo P, Guallar JP, Rodriguez de la Concepción ML, Alegre M, Domingo JC, Villarroya F. Antivir Ther; 2006 Dec 05; 11(6):729-40. PubMed ID: 17310817 [Abstract] [Full Text] [Related]
37. Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome. Ostrowski SR, Ullum H, Goka BQ, Høyer-Hansen G, Obeng-Adjei G, Pedersen BK, Akanmori BD, Kurtzhals JA. J Infect Dis; 2005 Apr 15; 191(8):1331-41. PubMed ID: 15776381 [Abstract] [Full Text] [Related]